Learn more

NBE THERAPEUTICS AG

Overview
  • Total Patents
    66
  • GoodIP Patent Rank
    22,358
  • Filing trend
    ⇧ 280.0%
About

NBE THERAPEUTICS AG has a total of 66 patent applications. It increased the IP activity by 280.0%. Its first patent ever was published in 2014. It filed its patents most often in United States, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and foods and drinks are L BASE CO LTD, SEAGEN INC and ONCOQUEST INC.

Patent filings per year

Chart showing NBE THERAPEUTICS AGs patent filings per year from 1900 to 2020

Focus industries

Top inventors

# Name Total Patents
#1 Grawunder Ulf 56
#2 Beerli Roger 36
#3 Waldmeier Lorenz 22
#4 Beerli Roger Renzo 20
#5 Gebleux Remy 12
#6 Ulf Grawunder 9
#7 Roger Renzo Beerli 8
#8 Hellmann Ina 7
#9 Pretto Francesca 4
#10 Rader Christoph 4

Latest patents

Publication Filing date Title
EP3647419A1 Sortase f and its use in methods for conjugation
EP3636284A1 Binding protein-toxin conjugates comprising anthracyclines, and use thereof in immune-oncological applications
CA3071212A1 Anthracycline-based antibody drug conjugates having high in vivo tolerability
EP3655435A1 Multispecific antibody product that binds to different ror1 epitopes
WO2019016392A1 Human antibodies binding to ror2
US2019112385A1 Anti-mesothelin antibodies
KR20180069067A Anti-ROR1 antibody
EP3256166A1 Maytansine-drug conjugates of her- 2 specific binding proteins generated by site specific sortase-enzyme mediated conjugation
CN107750169A Associated proteins drug conjugate comprising anthracycline derivative